Entresto (sacubitril/valsartan) - Novartis, ROVI Pharmaceuticals Laboratories
Association of Sacubitril/Valsartan Initiation with Changes in NT-proBNP and Self-Care Behavior in Heart Failure Patients with Reduced Ejection Fraction: A Real-World Single-Center Retrospective Study (ChiCTR) - Oct 16, 2026 - P=N/A | N=200 | Not yet recruiting | Sponsor: The Affiliated Hospital of Xuzhou Medical University; The Affiliated Hospital of Xuzhou Medical University 
New trial • Cardiovascular • Heart Failure
https://www.chictr.org.cn/showproj.html?proj=332403
 
Oct 16, 2026
 
Prev Next